Persons at Higher Risk Recommended for Antiviral Treatment for Suspected/Confirmed Influenza

Children <2 y of age
Adults ≥65 y of age
Persons with chronic pulmonary (including asthma), cardiovascular (except hypertension alone), renal, hepatic, hematologic (including sickle cell disease), or metabolic (including diabetes mellitus) disorders or neurologic and neurodevelopmental conditions (including disorders of the brain, spinal cord, peripheral nerve, and muscle, such as cerebral palsy, epilepsy [seizure disorders], stroke, intellectual disability [mental retardation], moderate-to-severe developmental delay, muscular dystrophy, or spinal cord injury)
Persons with immunosuppression, including that caused by medications or by HIV infection
Women who are pregnant or in the postpartum period (within 2 wk after delivery)
Persons aged <19 y who are receiving long-term aspirin therapy
American Indian/Alaska Native persons
Persons who are morbidly obese (ie, BMI ≥ 40)
Residents of nursing homes and other chronic care facilities
  • Data source: Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM; Centers for Disease Control and Prevention. MMWR Recomm Rep. 2011;60(RR-1):1–24.